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SUMMARY
Eight hundred and ninety-six patients were followed up cytologically for up to
21 years following treatment fora CIN/i1 lesion ofthe cervix. The recurrence rate
(8.8%) was lower after hysterectomy than after treatment which preserved the
cervix (23 %). Long-term yearly follow- up is not required as all recurrences were
detected by annual smears for a seven-year period after treatment in both
groups. It is important to keep patients under cytological review following
hysterectomy because of the appreciable recurrence rate and also evidence that
intraepithelial lesions of the vaginal vault behave in an aggressive fashion.
INTRODUCTION
Following treatment of cervical intraepithelial neoplasia (CIN), periodic cervical
smears are required to ensure that the lesion has been completely eradicated.
Long -term follow-up has been advocated." 2 In Northern Ireland, patients are
not uncommonly advised to have an annual smear until the age of sixty. There
would seem to be grounds for this practice. Surgical excision ofthe lesion is often
found on histological examination to be incomplete and, even in apparently
normal epithelium surrounding the lesion, there is often evidence of
papillomavirus infection which is thought to be associated with the development
of CIN.3,4 Recent suggestions that carcinoma of the cervix has become more
aggressive have also served to increase caution in the management of these
patients. Frequent follow-up has disadvantages for both the patient and the
laboratory service. A requirement for annual smears tends to set a woman apart
from her fellows, continually focuses attention on the cervix and may well
engender cancer-phobia. At the laboratory, cervical smears from these patients
require to be examined by seniorstaffand, since the Belfast City Hospital has now
been engaged in community screening for 22 years, a considerable number of
patients are undergoing frequent follow -up and are straining limited resources. It
is therefore important to determine safe guidelines for the management of these
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patients after treatment. At the Belfast City Hospital we were able to attempt this
because all patients found to have abnormal smears during our 22 years of
operation have been recorded on computer together with their biopsy results
and their subsequent history obtained by the follow-up programme which the
laboratory has operated.
METHOD
For this study we selected from our-records all those women who had had
treatment for a histologically proven. severe,cervical intraepithelial neoplasia (CIN
III lesion) between 1965 and 1983 and on whom we had follow-up cytology
smears and clinical information until September 1986. Most of the patients had
had annual smears following their treatment. The patients were divided into two
groups: those who had had cone biopsies (even though these often resulted in
apparently incomplete excisions) and those who were treated by hysterectomy.
Some of the biopsy group may have had subsequent cautery to the cervix. For
each of these groups we determined from our computer records the pattern of
recurrence of abnormal smears over a period extending to 21 years. We also
examined the biopsy reports of 100 of those patients who were treated by
excisional biopsy to obtain an indication of the proportion of patients in whom it
was felt that the lesion was probably not completely excised. In order to assess
their riskof invasive cancerwecompared a listofthose eventually lost tofollow-up
with a register of cases of invasive cancer in Northern Ireland from 1965 to 1987
previously compiled by the laboratory.
RESULTS
There were 896 women in our records who had been kept under clinical review
with cervical smears following treatment of a histologically proven CIN Ill lesion
of the cervix. Of these, 215 had had a hysterectomy following the initial biopsy,
and in 681 the lesion had been treated by excisional biopsy. The percentage of
patients subsequently having normal cervical smears in these two groups is
shown in life table form in the Figure, which illustrates the first 12 years of
follow-up. As expected, recurrence of an abnormal smear was much less
common in patients treated by hysterectomy, 19 (8.8%) of whom showed
evidence of recurrence in the vaginal vault. Ofthose in whom the lesion had been
excised, 157 (23%) had relapse in the cervix. This recurrence rate in those
treated by cone excision was, however, much lower than predicted by our review
of the histology, which showed that in 50% of the patients it did not appear that
the whole of the lesion had been removed. A striking feature is the similarity in
the time of the recurrence, whether the patient was treated by hysterectomy or
excisional biopsy. Most recurrences took place during the first two years with
smaller numbers relapsing until the sixth and seventh years after surgery.
Thereafter we found no further relapses even on prolonged follow-up to 21
years. The life table shows the recurrence rates as determined by a further
positive smear without regard to the severityofthesubsequent lesionas shown by
biopsy. Our records show that inall cases therecurrencewasstill apparently intra -
epithelial when first detected. However, in 12 cases invasive cancer eventually
developed. Five ofthese arose in the vaginal vault afterhysterectomy. Three were
patients in their sixth decade who had abnormal vault smears after hysterectomy,
© The Ulster Medical Society, 1987.
9192 The Ulster Medical Journal
100
1\98
X 269 13~5 1ilo _985 68 s 1 3 7 23 1 3 1 0
U)
W 90
cc
U.)
w s570
< ~ ~~~~~ "53
so80 ~ - 347 268
1 ~ ~ ~ 27 32 4 5 6 71 1 1 78 61 39 16 15
60-
1 2 3 4 5 6 7 8 9 10 11 12
YEARS
Figure. Follow -up cervical smear of patients with CIN lllafter hysterectomy ( , 215 patients)
or local treatment to the cervix (----, 681 patients). The results are given in life table form. Years
12 - 21 are not shown, there being no further relapses.
invasion occurring two years after operation. In a further two patients invasive
cancer was found eight years after operation although in each case the first smear
taken from the vault after hysterectomy was positive, there being no smears
taken in the intervening period. Two further vaginal carcinomas arose in patients
who had had their initial cervical lesion locally excised. Both had persistently
positive smears after operation, the invasive lesion developing three years later in
one and seven years later in the other, despite subsequent hysterectomy. There
were five invasive cervical cancers, three arising within the first two years of
operation. The other two developed the disease after eight and fifteen years
respectively. In both it was associated with inadequate follow-up although one
had a positive smear soon after cone biopsy.
DISCUSSION
Recurrence of cervical intraepithelial neoplasia (CIN) during the first two years
after treatment very probably reflects incomplete excision of the lesion in the
cervix or extension of the original lesion to the vaginal vault in those treated by
hysterectomy. The slower relapse rate for the next five years may result from the
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progressive developmentofepithelial changes which wereonlyat an early stageof
evolution at thetimeof operation, perhaps from epithelium remaining inthe cervix
showing no abnormality but already infected by the papillomavirus, currently
thought to be closely associated with mutagenesis. Reinfection with this virus is
also thought to occur frequently and could add to the relapse rate. Although in a
number of patients the lesion may have been eradicated by subsequent cautery it
is striking that only 23% patients relapsed. This contrasts with our biopsy review
which indicated that, even on histological criteria, which probably underestimates
the extent of epithelium infected by papillomavirus, about 50% of the lesions
were likely to recur.
A low rate of recurrence of severe dysplasia has been noted by others.1 5 These
surveys were, however, performed before the marked increase in prevalence of
both papillomavirus infections and CIN lesions of the cervix accompanied by
fears that cervical cancer was occurring in a more aggressive form. In Northern
Ireland there has been a threefold increase in the prevalence of positive smears
commencing in 1976 and it is reassuring that in our review, which includes
patients treated between 1976 and 1983, relapse rates including mild CIN
lesions remain low.
Although frequently commented upon,6 7 it has not been satisfactorily explained
whyCIN lesions may regress after partial removal. Itseems possible that immuno -
logical factors are involved. There are many types of human papillomavirus some
of which infect the skin producing the common wart. It has been shown that
mechanical or chemical damage to the skin lesion can induce immunologic
reaction with regression to the wart.8 Conversely, in immunosuppressed patients,
as following renal transplantation, both papillomavirus infection of the skin and
also CIN lesions of the cervix are increased in incidence.9 It would not be
unexpected therefore if biopsy of the cervix had a similar effect in promoting
immunologic resistance to the virus in the cervix.
Following excision of intraepithelial lesions of the cervix, follow,-up with annual
cervical smears is frequently advised for many years. Our results suggest that this
is unnecessary and that after seven negative annual smears it is safe to assume
that the lesion has been eradicated, further smears being taken at the normal
screening interval. In contrast, after hysterectomy it is the experience of this
laboratory that many clinicians are reluctant to arrange for follow,-up smears in
the beliefthat recurrence is unlikely and in the desire to spare patients the lengthy
follow,up practised for women who have retained their cervix. However, an 8.8%
recurrence rate is appreciable, and our results show that in this group too a seven -
year follow -up should be sufficient.
A further finding of interest in this review was that of the twelve cases of invasive
carcinoma known to us, seven arose in the vaginal epithelium. This suggests that
intraepithelial lesions are more aggressive in this site, and indeed Koss also
comments that in his experience vaginal dysplasias have a tendency to rapid
progression and should not be left unattended.10 This adds emphasis to our
recommendation for review of patients treated-by hysterectomy.
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